Citigroup Inc Beyond Spring Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Beyond Spring Inc. stock. As of the latest transaction made, Citigroup Inc holds 454,250 shares of BYSI stock, worth $931,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares

454,250

Holding current value

$931,212

% of portfolio

0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.76 - $3.6 $799,480 - $1.64 Million	454,250 New	454,250 $1.09 Million
Q3 2022 Nov 10, 2022	SELL	$0.97 - $1.81 $717 - $1,339	-740 Reduced 9.79%	6,815 $7,000
Q2 2022 Aug 10, 2022	SELL	$1.13 - $2.66 $75 - $178	-67 Reduced 0.88%	7,555 $11,000
Q1 2022 May 12, 2022	BUY	$1.68 - $5.01 $3,533 - $10,536	2,103 Added 38.1%	7,622 $17,000
Q4 2021 Feb 10, 2022	BUY	$4.02 - $16.84 $11,911 - $49,896	2,963 Added 115.92%	5,519 $25,000
Q3 2021 Nov 10, 2021	BUY	$9.26 - $31.31 $23,668 - $80,028	2,556 New	2,556 $40,000

Others Institutions Holding BYSI

# of Institutions

Shares Held

5.77M

Call Options Held

53.2K

Put Options Held

2.5K

View Full List

About BeyondSpring Inc.

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $79.8M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

More about BYSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account